author-photo

S.G. Swisher

University of Texas MD Anderson Cancer Center

12

Papers

64

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Characterization of the immune landscape of EGFR-mutant NSCLC identifies CD73/adenosine pathway as a potential therapeutic target.

2020 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (14)
OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (18)
Immune and circulating tumor DNA profiling following radiation treatment for oligometastatic NSCLC; translational correlatives from a mature randomized phase II trial

2019 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (15)
Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer

2019 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (10)
MA11.11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (2)
MA03.05 BRAF Mutations Are Associated with Increased Benefit from PD1/PDL1 Blockade Compared with Other Oncogenic Drivers in Non-Small Cell Lung Cancer

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MA11.09 Increased Frequency of Bystander T Cells in the Lungs Is Associated with Recurrence in Localized Non-Small Cell Lung Cancer

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)